Polymorphism of human cytochrome P450 enzymes and its clinical impact.
about
Applications of CYP450 testing in the clinical settingChallenges, Solutions, and Quality Metrics of Personal Genome Assembly in Advancing Precision MedicineThe pharmacogenomics of pain management: prospects for personalized medicineSphingolipids and Epoxidized Lipid Metabolites in the Control of Gut Immunosurveillance and AllergymicroRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentImpact of New Genomic Technologies on Understanding Adverse Drug ReactionsInteractions between CYP3A4 and Dietary PolyphenolsPolymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancersPolymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapyEvaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicityCrystal Structure of Human Cytochrome P450 2D6 with Prinomastat BoundPharmacogenomic discovery using cell-based modelsCytochrome P450-mediated drug metabolism in the brainGene expression variability in human hepatic drug metabolizing enzymes and transportersCYP2C9 genotype vs. metabolic phenotype for individual drug dosing--a correlation analysis using flurbiprofen as probe drugUse of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by StilbenesSmoking, the xenobiotic pathway, and clubfootDetoxiProt: an integrated database for detoxification proteinsUtilization of genetic tests: analysis of gene-specific billing in Medicare claims data.Pharmacogenetic testing revisited: 5' nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19.Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodesSimultaneous determination of sibutramine and its active metabolites in human plasma by LC-MS/MS and its application to a pharmacokinetic study.Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions.Tumoral expression of drug and xenobiotic metabolizing enzymes in breast cancer patients of different ethnicities with implications to personalized medicine.CYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response.Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral responseAccelerated hypertension after venlafaxine usageClinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disordersAssociation between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controlsCytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.CYP2E1 gene rs6413420 polymorphism was first found in the Bouyei ethnic group of China.Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes.Molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa.New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia.Cytochrome P450 (CYP2D6) genotype is associated with elevated systolic blood pressure in preterm infants after discharge from the neonatal intensive care unit.Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatmentInhibition of baicalin on metabolism of phenacetin, a probe of CYP1A2, in human liver microsomes and in rats.
P2860
Q24621760-2152F657-A4F1-43F2-9EB5-C11F6A0DA844Q26750544-17ACE5E6-48E3-453B-9FC4-DB20E9E4FE44Q26765266-0E4181E6-C232-4B69-B291-6509C0699776Q26767382-CA3771A8-E34F-4230-8EF7-13F437D858A7Q26778918-EC9FE884-F6A7-4616-991C-79A80315A8B6Q26787099-8EBA9DD7-8989-4F13-AD3F-07CFA2CF5454Q26800893-648D049E-99A2-43F7-8A62-509A5ECD5391Q27010137-8E0C31FD-A3A8-4F7C-8F9B-3B5A682FEC51Q27022665-1D3B70CE-876E-4382-B9FE-91406BE7B07CQ27027301-31E06235-3A73-4A76-A63D-3A153D2552D8Q27677093-DD9CACC1-448F-4965-A968-6E7972DFBEE2Q28392982-A70BCC2F-3DAB-4716-AA36-A475FDE9E949Q28397217-595AC600-A9B5-4C41-8519-E1630868B512Q28486732-BB92DE74-178E-472C-8E82-999533B9E946Q28544111-3BB3E84C-8B93-4AF9-AEE9-1508F95BB239Q28550408-FD2783E6-A142-4EE5-B56E-A1CC28BF14D0Q28672873-7DF455CC-301C-49F5-A183-E03B3A10275FQ30427279-0871662F-C0CB-476A-A1A4-2F317BD9B4EDQ31157018-3946B463-201B-48CE-AB85-CEBEFF54E977Q33597438-418FC882-B5AB-41A8-946F-89D9467595FDQ33743556-E64CB48D-9523-4901-B26F-8AB0BEBB99FDQ33811844-E74AE8A7-D5B0-4FEE-956B-D93C160BB9D2Q33867239-A113321E-47E1-446A-892B-81115D4D94B9Q33881477-6859982D-479F-4F74-A4B8-0EC07926B6A8Q33888862-DB3E9296-3BB0-47C2-BCDD-2C4E5D467914Q34165511-EB371140-D65F-4776-A200-B03F39442748Q34173696-162EAAA7-4BD9-4A24-807A-C5F1D9B2D29AQ34311469-B44B902E-ECFB-46AB-A1B4-5097CE6332D6Q34391577-BABE8200-0FD8-41F8-8C24-5B87CCD463C5Q34442590-6C3CF6AC-3D7D-43E9-B3EC-3187AF3DE925Q34491448-081C6E4C-4721-4A42-943F-C20E51954A87Q34547680-C79B70A6-7CBC-4805-B042-7C6CD90ECB41Q34702564-2052A059-99B7-464C-B31C-721C5EE2BB51Q34704763-38D9F2A9-A745-455A-8A1E-85EFEA2DBE97Q34994964-ADA0A4E9-9247-40E8-BFA0-DAF9FB1803D1Q35015993-6BA2F427-51C6-4A28-8753-0B79F90753D4Q35036312-63CD8049-F72C-4A4E-99D9-E68E8D3E30C8Q35046594-1C213A54-4014-4873-877C-0903B238D3B7Q35087543-DB67245C-ED8F-4552-A868-60311599801AQ35108016-CACD9B97-57BB-4D5E-B71F-98835727CBE9
P2860
Polymorphism of human cytochrome P450 enzymes and its clinical impact.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polymorphism of human cytochrome P450 enzymes and its clinical impact.
@en
Polymorphism of human cytochrome P450 enzymes and its clinical impact.
@nl
type
label
Polymorphism of human cytochrome P450 enzymes and its clinical impact.
@en
Polymorphism of human cytochrome P450 enzymes and its clinical impact.
@nl
prefLabel
Polymorphism of human cytochrome P450 enzymes and its clinical impact.
@en
Polymorphism of human cytochrome P450 enzymes and its clinical impact.
@nl
P2093
P1476
Polymorphism of human cytochrome P450 enzymes and its clinical impact.
@en
P2093
Balram Chowbay
Jun-Ping Liu
Shu-Feng Zhou
P304
P356
10.1080/03602530902843483
P407
P577
2009-01-01T00:00:00Z